Vuab Pharma As, based in Czech Republic, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NYSTATIN USP, with a corresponding US DMF Number 14056.
Remarkably, this DMF maintains an Active status since its submission on April 05, 1999, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on January 09, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II